APA
Cukierman D. S., Pinheiro A. B., Castiñeiras-Filho S. L. P., da Silva A. S. P., Miotto M. C., De Falco A., de P Ribeiro T., Maisonette S., da Cunha A. L. M. C., Hauser-Davis R. A., Landeira-Fernandez J., Aucélio R. Q., Outeiro T. F., Pereira M. D., Fernández C. O. & Rey N. A. (20170918). A moderate metal-binding hydrazone meets the criteria for a bioinorganic approach towards Parkinson's disease: Therapeutic potential, blood-brain barrier crossing evaluation and preliminary toxicological studies. : Journal of inorganic biochemistry.
Chicago
Cukierman Daphne Schneider, Pinheiro Ana Beatriz, Castiñeiras-Filho Sergio L P, da Silva Anastácia Sá P, Miotto Marco C, De Falco Anna, de P Ribeiro Thales, Maisonette Silvia, da Cunha Alessandra L M C, Hauser-Davis Rachel A, Landeira-Fernandez J, Aucélio Ricardo Q, Outeiro Tiago F, Pereira Marcos D, Fernández Claudio O and Rey Nicolás A. 20170918. A moderate metal-binding hydrazone meets the criteria for a bioinorganic approach towards Parkinson's disease: Therapeutic potential, blood-brain barrier crossing evaluation and preliminary toxicological studies. : Journal of inorganic biochemistry.
Harvard
Cukierman D. S., Pinheiro A. B., Castiñeiras-Filho S. L. P., da Silva A. S. P., Miotto M. C., De Falco A., de P Ribeiro T., Maisonette S., da Cunha A. L. M. C., Hauser-Davis R. A., Landeira-Fernandez J., Aucélio R. Q., Outeiro T. F., Pereira M. D., Fernández C. O. and Rey N. A. (20170918). A moderate metal-binding hydrazone meets the criteria for a bioinorganic approach towards Parkinson's disease: Therapeutic potential, blood-brain barrier crossing evaluation and preliminary toxicological studies. : Journal of inorganic biochemistry.
MLA
Cukierman Daphne Schneider, Pinheiro Ana Beatriz, Castiñeiras-Filho Sergio L P, da Silva Anastácia Sá P, Miotto Marco C, De Falco Anna, de P Ribeiro Thales, Maisonette Silvia, da Cunha Alessandra L M C, Hauser-Davis Rachel A, Landeira-Fernandez J, Aucélio Ricardo Q, Outeiro Tiago F, Pereira Marcos D, Fernández Claudio O and Rey Nicolás A. A moderate metal-binding hydrazone meets the criteria for a bioinorganic approach towards Parkinson's disease: Therapeutic potential, blood-brain barrier crossing evaluation and preliminary toxicological studies. : Journal of inorganic biochemistry. 20170918.